Dabrafenib and trametinib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Dabrafenib and trametinib, covering 2020-01-21 to 2020-01-21. Get the full timeline:
Most recent: Clinical Trial Update: Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma [Phase 2]